Vascular diseases

The Food and Drug Administration (FDA) Determines that Women Taking Addyi May Safely Consume Alcohol

Retrieved on: 
Friday, April 12, 2019

This decision was informed by three new Addyi alcohol interaction studies which demonstrated no syncope or orthostatic hypotension requiring medical attention.

Key Points: 
  • This decision was informed by three new Addyi alcohol interaction studies which demonstrated no syncope or orthostatic hypotension requiring medical attention.
  • Sprout received the FDA ordered Addyi labeling change to lessen the alcohol restriction on April 11, 2019.
  • "FDA, like us, recognizes that women want access to treatment for this condition and their label order reflecting that women taking Addyi may safely consume alcohol is a positive step.
  • Addyi is the first and only FDA-approved treatment for acquired, generalized hypoactive (low) sexual desire disorder (HSDD) for premenopausal women.

The global neurovascular devices market size is estimated to reach USD 3.1 billion by 2026

Retrieved on: 
Monday, April 8, 2019

NEW YORK, April 8, 2019 /PRNewswire/ -- Neurovascular Devices Market Size, Share & Trends Analysis Report By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm), By Device Type, By Region, And Segment Forecasts, 2019 - 2026

Key Points: 
  • NEW YORK, April 8, 2019 /PRNewswire/ -- Neurovascular Devices Market Size, Share & Trends Analysis Report By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm), By Device Type, By Region, And Segment Forecasts, 2019 - 2026
    The global neurovascular devices market size is estimated to reach USD 3.1 billion by 2026 The market is estimated to expand at a CAGR of 5.3% over the forecast years.
  • Preference for minimally invasive surgeries in the treatments of brain aneurysm and stroke is expected to be the key factor augmenting the market growth.
  • Therefore, rise in aging population across the globe is anticipated to impel the demand for neurovascular devices.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Worldwide Intracranial Stents Market Study, 2019: The Market was $293.7M in 2017, and is Projected to Reach $691.2M by 2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 8, 2019

The global Intracranial Stents market was valued at USD 293.7 Mn in 2017 and is expected to reach USD 691.2 Mn by 2026, expanding at a CAGR of 9.9% from 2018 to 2026.

Key Points: 
  • The global Intracranial Stents market was valued at USD 293.7 Mn in 2017 and is expected to reach USD 691.2 Mn by 2026, expanding at a CAGR of 9.9% from 2018 to 2026.
  • The type of intracranial stents present in the market is self-expanding intracranial stents, balloon expanding stents, and stent-assisted coil embolization.
  • On the basis of diseases, intracranial stents market is segmented as intracranial stenosis and brain aneurysm out of which intracranial stenosis was observed as the largest market.
  • The intracranial stents market is growing significantly and major companies present in this market are focusing on the development of safe & efficient intracranial stents.

United States Blood Pressure Monitoring Markets to 2025

Retrieved on: 
Thursday, March 28, 2019

DUBLIN, March 28, 2019 /PRNewswire/ -- The "Blood Pressure Monitoring Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 28, 2019 /PRNewswire/ -- The "Blood Pressure Monitoring Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.
  • The personal market is set to increase as more Americans adopt blood pressure monitoring practices.
  • Hypertension refers to instances where an individual's blood pressure is more elevated than normal.
  • Hypotension refers to instances where the individual's blood pressure is lower than normal.

United States Blood Pressure Monitoring Market Report 2019-2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 27, 2019

The "Blood Pressure Monitoring Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Blood Pressure Monitoring Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.
  • The personal market is set to increase as more Americans adopt blood pressure monitoring practices.
  • Hypertension refers to instances where an individual's blood pressure is more elevated than normal.
  • Hypotension refers to instances where the individual's blood pressure is lower than normal.

Diabetic Nephropathy Pipeline Insight Report 2019: Pipeline (Under Development), Therapeutics Scenario and Growth Prospects

Retrieved on: 
Wednesday, March 27, 2019

DUBLIN, March 27, 2019 /PRNewswire/ -- The "Diabetic Nephropathy - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 27, 2019 /PRNewswire/ -- The "Diabetic Nephropathy - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Nephropathy development.
  • The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
  • The report assesses the active Diabetic Nephropathy pipeline products by developmental stage, product type, molecule type, and administration route.

Endospan Secures CE Mark Approval for Branched Endovascular Repair of the Aortic Arch with Its NEXUS™ Aortic Arch Repair System

Retrieved on: 
Tuesday, March 19, 2019

Endospan , a pioneer in off-the-shelf, minimally invasive endovascular repair of Aortic Arch Disease comprising both aneurysms and dissections, today announced that it has received CE-marking for its NEXUS Stent Graft System.

Key Points: 
  • Endospan , a pioneer in off-the-shelf, minimally invasive endovascular repair of Aortic Arch Disease comprising both aneurysms and dissections, today announced that it has received CE-marking for its NEXUS Stent Graft System.
  • The CE mark approval for NEXUS represents a major milestone being the first low-profile branched endovascular stent-graft to be available off-the-shelf to cardiovascular specialists in Europe, enabling them to now perform standardized minimally invasive repair of the aortic arch.
  • Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of Aortic Arch Disease, both aneurysms and dissections.
  • With CE-marking in Europe, the NEXUS Stent Graft System is the first endovascular off-the-shelf system to treat Aortic Arch Disease: a greatly underserved group of patients diagnosed with a dilative lesion in, or near, the aortic arch.

Intracranial Stents Market to Achieve US$705.5 Million by 2026, Noted TMR

Retrieved on: 
Tuesday, March 19, 2019

Based on the product type, the intracranial stents market is categorized into self-expanding intracranial stents, and embolization coil support intracranial stents.

Key Points: 
  • Based on the product type, the intracranial stents market is categorized into self-expanding intracranial stents, and embolization coil support intracranial stents.
  • On the basis of disease indication, the global intracranial stents market is segmented into brain aneurysm and intracranial stenosis.
  • The intracranial stents market North America is primarily driven by an increase in the adoption of technologically advanced intracranial stents, along with presence of key established players in the region.
  • However, the intracranial stents market appears to be highly concentrated due to the presence of few vendors in the market.

Intracranial Stents Market to Achieve US$705.5 Million by 2026, Noted TMR

Retrieved on: 
Tuesday, March 19, 2019

Based on the product type, the intracranial stents market is categorized into self-expanding intracranial stents, and embolization coil support intracranial stents.

Key Points: 
  • Based on the product type, the intracranial stents market is categorized into self-expanding intracranial stents, and embolization coil support intracranial stents.
  • On the basis of disease indication, the global intracranial stents market is segmented into brain aneurysm and intracranial stenosis.
  • The intracranial stents market North America is primarily driven by an increase in the adoption of technologically advanced intracranial stents, along with presence of key established players in the region.
  • However, the intracranial stents market appears to be highly concentrated due to the presence of few vendors in the market.

Diabetic Nephropathy Pipeline Insight Report 2019 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 8, 2019

The "Diabetic Nephropathy - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Diabetic Nephropathy - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Nephropathy development.
  • The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
  • The report assesses the active Diabetic Nephropathy pipeline products by developmental stage, product type, molecule type, and administration route.